Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Amantadine Hydrochloride for Treatment of Symptoms of the Post-traumatic Confusional State Among Neurorehabilitation Admissions With TBI: A Randomized, Double-Blind, Placebo-Controlled Trial

NCT00693121 is registered in ClinicalTrials.gov with Methodist Rehabilitation Center as lead sponsor.

NCT NCT00693121
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00693121 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Amantadine Hydrochloride for Treatment of Symptoms of the Post-traumatic Confusional State Among Neurorehabilitation Admissions With TBI: A Randomized, Double-Blind, Placebo-Controlled Trial
Lead sponsor
Methodist Rehabilitation Center
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2003
Completion date
March 31, 2019
Enrollment
79 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

delirium, posttraumatic confusional state, traumatic brain injury